“Digital endpoints must provide a clear return on investment so they may progress from the research and development realm and deliver on the promise of these technologies and measures. The resources developed in this project will provide decision-makers with tools and confidence to evaluate the value of using digital health technology in a registrational clinical trial.”

– Dudley Tabakin | Founder and Chief Executive Officer, VivoSense